Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'glutamate' OR with Authors including 'glutamate' OR with Abstract including 'glutamate' OR with Keywords including 'glutamate'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Bramwell GJ, Gonye T Responses of midbrain neurones to iontophoretically applied 5-hydroxyt... Brit.J.Pharmacol. 1973
Bradley PB, Briggs I Further Studies On The Mode Of Action Of Psychotomimetic Drugs: Antago... Br. J. Pharmac. 1974
Gey KF, Georgi H Effect Of Neurotropic Agents On Total Pyridoxal, Phosphate And On The ... J Neurochem. 1974
Bradley PB, Griggs I Actions of Serotonin and Related Substances on Single Neurons in the B... Advanc Biochem Psych... 1974
Freedman DX LSD, Psychotogenic Procedures, and Brain Neurohumors. Psychopharmacol Bull 1975
Bramwell GJ, Goenye T Responses of Midbrain Neurones to Micro-Iontophoretically Applied 5-Hy... Neuropharmacology 1976
Briggs I Excitatory Responses of Neurones in Rat Bulbar Reticular Formation to ... J.Physiol. 1977
Smythies JR On The Molecular Mechanism Of Action Of Hallucinogens The Psychopharmacolo... 1978
Greengard P Cyclic nucleotides, phosphorylated proteins and the nervous system Federation Proc. 1979
Mccall RB, Aghajanian GK Hallucinogens Potentiate Responses To Serotonin And Norepinephrine In ... Life Sciences 1980
Olney JW, Labruyere J, Pr... Pathological changes induced in cerebrocortical neurons by phencyclidi... Science 1989
Ashby CR, Edwards E, Hark... Effects of (+/-)-DOI on medial prefrontal cortical cells: a microionto... Brain Res 1989
Gibb JW, Johnson M, Hanso... Neurochemical basis of neurotoxicity Neurotoxicology 1990
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Olney JW, Labruyere J, Wa... NMDA antagonist neurotoxicity: mechanism and prevention Science 1991
Nash JF, Yamamoto BK Methamphetamine neurotoxicity and striatal glutamate release: comparis... Brain Res 1992
White SR, Duffy P, Kaliva... Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firi... Neuroscience 1994
Rossner S, Schliebs R, Bi... Ibotenic acid lesion of nucleus basalis magnocellularis differentially... Brain Res 1994
Farfel GM, Seiden LS Role of hypothermia in the mechanism of protection against serotonergi... J Pharmacol Exp Ther 1995
White SR, Harris GC, Imel... Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA... Brain Res 1995
Banerjee PK, Snead OC Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric aci... J Pharmacol Exp Ther 1995
Finnegan KT, Taraska T Effects of glutamate antagonists on methamphetamine and 3,4-methylened... J Neurochem 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Pu C, Broening HW, Vorhee... Effect of methamphetamine on glutamate-positive neurons in the adult a... Synapse 1996
Shen M, Piser TM, Seybold... Cannabinoid receptor agonists inhibit glutamatergic synaptic transmiss... J Neurosci 1996
Kombian SB, Zidichouski J... GABAB receptors presynaptically modulate excitatory synaptic transmiss... J Neurophysiol 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Gleitz J, Friese J, Beile... Anticonvulsive action of (+/-)-kavain estimated from its properties on... Eur J Pharmacol 1996
Kombian SB, Saleh TM, Fia... Ibogaine and a total alkaloidal extract of Voacanga africana modulate ... Brain Res Bull 1997
Colado MI, Granados R, O'... Role of hyperthermia in the protective action of clomethiazole against... Br J Pharmacol 1998
Obradovic T, Imel KM, Whi... Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... Brain Res 1998
Farber NB, Hanslick J, Ki... Serotonergic agents that activate 5HT2A receptors prevent NMDA antagon... Neuropsychopharmacol... 1998
Obradovic T, Imel KM, Whi... Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... Brain Res 1998
Wickelgren I Teaching the brain to take drugs Science 1998
Shen M, Thayer SA Cannabinoid receptor agonists protect cultured rat hippocampal neurons... Mol Pharmacol 1998
Aghajanian GK, Marek GJ Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal ... Brain Res 1999
Berman RM, Cappiello A, A... Antidepressant effects of ketamine in depressed patients Biol Psychiatry 2000
West WB, Lou A, Pechersky... Antagonism of a PCP drug discrimination by hallucinogens and related d... Neuropsychopharmacol... 2000
Nicotra AS, Parvez H Nitric Oxide and Neuronal and Pancreatic Beta Cell Death Toxicology 2000
Fischer HS, Zernig G, Sch... MDMA ('ecstasy') enhances basal acetylcholine release in brain slices ... Eur J Neurosci 2000
Schatz DS, Kaufmann WA, S... 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein ... Synapse 2000
Mansvelder HD, McGehee DS Long-term potentiation of excitatory inputs to brain reward areas by n... Neuron 2000
Braff, DL, Geyer, MA and ... Human studies of prepulse inhibition of startle: normal subjects, pati... Psychopharmacology 2001
Vollenweider FX, Geyer MA A systems model of altered consciousness: integrating natural and drug... Brain Res Bull 2001
Krupitsky EM, Burakov AM,... Attenuation of ketamine effects by nimodipine pretreatment in recoveri... Neuropsychopharmacol... 2001
Mechoulam R, Panikashvili... Cannabinoids and brain injury: therapeutic implications Trends Mol Med 2002
Nichols CD, Sanders-Bush ... A single dose of lysergic acid diethylamide influences gene expression... Neuropsychopharmacol... 2002
Whitworth TL, Herndon LC,... Psychostimulants differentially regulate serotonin transporter express... J Neurosci 2002
van der Stelt M, Veldhuis... Acute neuronal injury, excitotoxicity, and the endocannabinoid system Mol Neurobiol 2002
Gandolfi O, Gaggi R, Volt... The activation of serotonin receptors prevents glutamate-induced neuro... Pharmacol Res 2002
Umbricht D, Vollenweider ... Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Gene... Neuropsychopharmacol... 2002
Weinbroum AA Importance of early identification of methylenedioxymethamphetamine ('... Eur J Emerg Med 2003
Croxford JL Therapeutic potential of cannabinoids in CNS disease CNS Drugs 2003
Bogen IL, Haug KH, Myhre ... Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and v... Neurochem Int 2003
van der Stelt M, Hansen H... Biosynthesis of endocannabinoids and their modes of action in neurodeg... Neurotox Res 2003
Stuerenburg HJ, Petersen ... Plasma amino acids in ecstasy users Neuroendocrinol Lett 2003
Johnson EA, O\'Callaghan ... Brain concentrations of d-MDMA are increased after stress Psychopharmacology (... 2004
Nichols DE Hallucinogens Pharmacology & Thera... 2004
Ostroff R, Gonzales M, Sa... Antidepressant Effect of Ketamine During ECT Am J Psychiatry 2005
Lambe EK, Aghajanian GK Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Co... Neuropsychopharmacol... 2005
Narendran R, Frankle WG, ... Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... Am J Psychiatry 2005
Ranjan S, Chandra PS Modafinil-induced irritability and aggression?: a report of 2 bipolar ... J Clin Psychopharmac... 2005
Wolff K, Winstock AR Ketamine : from medicine to misuse CNS Drugs 2006
Zarate CA, Singh JB, Carl... A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... Arch Gen Psychiatry 2006
Beique JC, Imad M, Mladen... Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation... Proc Natl Acad Sci U... 2007
Benneyworth MA, Xiang Z, ... A selective positive allosteric modulator of metabotropic glutamate re... Mol Pharmacol 2007
Chipana C, Camarasa J, Pu... Memantine prevents MDMA-induced neurotoxicity Neurotoxicology 2008
Deakin JF, Lees J, McKie ... Glutamate and the neural basis of the subjective effects of ketamine: ... Arch Gen Psychiatry 2008
Gonzalez-Maeso J, Ang RL... Identification of a serotonin/glutamate receptor complex implicated in... Nature 2008
Bossong MG, Niesink RJ Adolescent brain maturation, the endogenous cannabinoid system and the... Prog Neurobiol 2010
Vollenweider FX, Kometer ... The neurobiology of psychedelic drugs: implications for the treatment ... Nat Rev Neurosci 2010
Sanacora G, Smith MA, Pat... Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... Mol Psychiatry 2013
Lally N, Nugent AC, Lucke... Anti-anhedonic effect of ketamine and its neural correlates in treatme... Transl Psychiatry 2014
Elston TW, Pandian A, Smi... Aniracetam does not alter cognitive and affective behavior in adult C5... PLoS One 2014
Schifano F, Orsolini L, D... Novel psychoactive substances of interest for psychiatry World Psychiatry 2015
Battleday RM, Brem AK Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived... Eur Neuropsychopharm... 2015
Henderson TA Practical application of the neuroregenerative properties of ketamine:... Neural Regen Res 2016
Ingram R, Kang H, Lightma... Some distorted thoughts about ketamine as a psychedelic and a novel hy... Neuropharmacology 2018
Bertron JL, Seto M, Linds... DARK Classics in Chemical Neuroscience: Phencyclidine (PCP) ACS Chem Neurosci 2018
Zamberlan F, Sanz C, Vivo... The varieties of the psychedelic experience: a preliminary study of th... Front. Integr. Neuro... 2018
Botanas CJ, de la Peņa JB... Methoxetamine: A foe or friend? Neurochem Int 2019
Bennett R, Yavorsky C, Br... Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and P... Front Psychiatry 2022